Keywords: Actelion, Cost savings, R&D activity, Ipsen, Industrial facility

Actelion announces cost saving initiative; Ipsen to hang on to Dreux

Article | 12 July 2012

Print This

Europe largest biotech firm, Actelion (SIX: ATLN) this morning said it has launched a cost saving initiative as an integral ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in